Zydus Lifesciences (previously Cadila Healthcare) said that its subsidiary Zydus Pharmaceuticals (USA) Inc. has launched Topiramate Extended-Release Capsules in the US. The launch follows the final approval received by Zydus Pharmaceuticals (USA) from the US Food and Drug Administration (FDA) for marketing Topiramate Extended-Release Capsules, USP 25 mg, 50 mg, and 100 mg. The approved […]
Zydus Lifesciences (formerly known as Cadila Healthcare) has secured final approvals from the US Food and Drug Administration (FDA) for Silodosin Capsules, 4 mg and 8 mg and Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg. The two generic drugs will be manufactured by […]
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day, and 0.1 mg/day from the US Food and Drug Administration (FDA). The approved product is a generic version of Vivelle-Dot Transdermal System. Estradiol Transdermal System has FDA approval for the treatment of moderate […]
Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial from the US Food and Drug Administration (FDA). The approved product is a generic version of Levothyroxine Sodium injection manufactured by Fresenius Kabi USA. Levothyroxine Sodium injection […]
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg from the US Food and Drug Administration (FDA). Bisoprolol Fumarate and Hydrochlorothiazide tablets is a generic version of Ziac tablets. The combination of Bisoprolol Fumarate and hydrochlorothiazide has approval for […]
Zydus Lifesciences Limited (formerly Cadila Healthcare) said that it has secured final approval from the US Food and Drug Administration (FDA) for Acetaminophen Injection, 1,000 mg/100 mL (10 mg/mL) single-dose vials. The product is the generic of Ofirmev. It is approved for easing mild to moderate pain and bringing down fever. Ofirmev also has the […]
Zydus Lifesciences (formerly Cadila Healthcare) has secured final approval for Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials from the US Food and Drug Administration (FDA). The product is the generic version of Mycamine, and has approval for the treatment of a range of fungal infections. Besides, Micafungin for Injection, 50 mg/vial and […]
Zydus Lifesciences Limited (previously Cadila Healthcare Limited) has secured final approval for its analgesic drug Ketorolac Tromethamine Tablets USP, 10 mg from the US Food and Drug Administration (FDA). The approved product is a generic version of Toradol. Ketorolac Tromethamine Tablets are approved for their use in easing moderately severe pain, commonly after surgery. According […]
Zydus Lifesciences (previously called Cadila Healthcare) said that its subsidiary Zydus Worldwide DMCC has been given tentative approval from the US Food and Drug Administration (FDA) for Valbenazine Capsules USP 40 mg, 60 mg, and 80 mg. The product is a generic of Neurocrine Biosciences’ Ingrezza, which was approved by the FDA in 2017. According […]
Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has bagged final approval to market Brivaracetam Tablets USP 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg from the US Food and Drug Administration (FDA). The product is a generic of Briviact, which has approval for the treatment of […]